Trial Details

Recruiting
Basic Information
Clinical ID c5166
Identifier DRKS00030960
Trial Title Metabolic Profiling of Inflammatory Bowel Disease in Children and Adolescents - MetabIBD
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions K50 K51 K52;Crohn disease [regional enteritis];Ulcerative colitis;Other noninfective gastroenteritis and colitis
Interventions Group 1: Pediatric IBD patients receiving Infliximab - Observational group, longitudinal measurement of the metabolome in different biofluids.Group 2: Pediatric IBD patients receiving Adalimumab - Observational group, longitudinal measurement of the m
Participant Information
Sponsor Universitsklinikum Heidelberg, Klinik f Kinderheilkunde I
City NULL
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type observational
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL